LiBang Pharmaceuticals (09637) received a total of over 1.32 million shares in increased holdings from GIC and LAV, involving nearly HK$59 million.

Zhitong Finance APP learned that on June 29th, L.B. Pharmaceuticals (09637) received simultaneous increased holdings from two important institutional shareholders. Among them, GIC Private Limited, a Singaporean government investment company, increased its holdings by 872,000 shares at a price of HK$44.0844 per share, with a total amount of approximately HK$384.16 million. The shareholding has increased to 16.1 million shares, accounting for 7.09% of the total shares.